Latest News & Updates
Breaking News
9 hours ago
Simantini Singh Deo
Other trending news you may like to read
Cartesian Therapeutics Appoints Biopharma Veteran Dr. Adrian Bot To Board Of Directors, Adds Expertise In CAR T, RNA-Based Medicines, And Cell Therapy Innovations
Cartesian names industry veteran Adrian Bot to its Board of Directors, adding deep expertise in CAR T, RNA, and immune therapies.
Simantini Singh Deo
Alvotech And Teva Secure U.S. Settlement Date For AVT06, Proposed Biosimilar To Eylea®, Targeting Q4 2026 Launch
Alvotech and Teva secure a U.S. settlement with Regeneron, paving the way for AVT06 Eylea biosimilar launch in 2026.
Simantini Singh Deo
Biofrontera Completes FDA NDA And IND Transfers For Ameluz® And RhodoLED® Lamps, Gains Full US Regulatory And IP Control
Biofrontera finalizes FDA and IP transfers for Ameluz and RhodoLED, strengthening U.S. regulatory control and market position.
Simantini Singh Deo
Sangamo Therapeutics Begins Rolling FDA Submission For ST-920 Gene Therapy To Treat Adults With Fabry Disease
Sangamo initiates a rolling FDA BLA for ST-920, a one-time gene therapy targeting the underlying cause of Fabry disease.
Simantini Singh Deo
